Covid-19 : The impact of lockdown on the dispensing of hospital drugs to outpatients
Introduction: In response to the COVID-19 pandemic, France was under lockdown for the first time from March 17 to May 10, 2020.
Purpose of the Research: The aim of this work is to study the impact of lockdown on outpatients’ visits to the hospital pharmacy to collect chronic medication, in order to highlight the pharmaceutical classes concerned and to assess whether a decrease in medication adherence could be observed.
Method: Retrospectively, using hospital dispensing traceability software, the dispensing of drugs during the eight weeks of lockdown was compared with that during the two eight-week periods before and after lockdown. Evolutions in the number of medicine lines dispensed and outpatient visits were analyzed over the three time periods, according to pharmaceutical classes. A specific analysis was performed between drugs only available at the hospital pharmacy and drugs available at both the community and hospital pharmacy.
Results: During lockdown, 67% of patients still came regularly, but a significant decrease in the average number of lines dispensed was observed. 15% of regular patients limited their visits during this period. Patients taking drugs available at both the community and hospital pharmacy were significantly more impacted than those taking drugs that could only be dispensed at the hospital pharmacy. On the other hand, age is not a factor associated with the restriction of visits.
Conclusions: Lockdown affected the visits to the hospital pharmacy of at least one in ten regular outpatients. Sending hospital drugs to community pharmacies and the help of home health care providers limited therapeutic disruptions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
---|---|
Enthalten in: |
Sante publique (Vandoeuvre-les-Nancy, France) - 35(2024), 6 vom: 23. Feb., Seite 39-51 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
COVID-19 : répercussions du confinement sur l’activité de délivrance des médicaments en rétrocession |
---|
Beteiligte Personen: |
Aghnatios, Lucas [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.3917/spub.236.0039 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368783855 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM368783855 | ||
003 | DE-627 | ||
005 | 20240229155433.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.3917/spub.236.0039 |2 doi | |
028 | 5 | 2 | |a pubmed24n1306.xml |
035 | |a (DE-627)NLM368783855 | ||
035 | |a (NLM)38388400 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Aghnatios, Lucas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Covid-19 |b The impact of lockdown on the dispensing of hospital drugs to outpatients |
246 | 3 | 3 | |a COVID-19 : répercussions du confinement sur l’activité de délivrance des médicaments en rétrocession |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.02.2024 | ||
500 | |a Date Revised 26.02.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Introduction: In response to the COVID-19 pandemic, France was under lockdown for the first time from March 17 to May 10, 2020 | ||
520 | |a Purpose of the Research: The aim of this work is to study the impact of lockdown on outpatients’ visits to the hospital pharmacy to collect chronic medication, in order to highlight the pharmaceutical classes concerned and to assess whether a decrease in medication adherence could be observed | ||
520 | |a Method: Retrospectively, using hospital dispensing traceability software, the dispensing of drugs during the eight weeks of lockdown was compared with that during the two eight-week periods before and after lockdown. Evolutions in the number of medicine lines dispensed and outpatient visits were analyzed over the three time periods, according to pharmaceutical classes. A specific analysis was performed between drugs only available at the hospital pharmacy and drugs available at both the community and hospital pharmacy | ||
520 | |a Results: During lockdown, 67% of patients still came regularly, but a significant decrease in the average number of lines dispensed was observed. 15% of regular patients limited their visits during this period. Patients taking drugs available at both the community and hospital pharmacy were significantly more impacted than those taking drugs that could only be dispensed at the hospital pharmacy. On the other hand, age is not a factor associated with the restriction of visits | ||
520 | |a Conclusions: Lockdown affected the visits to the hospital pharmacy of at least one in ten regular outpatients. Sending hospital drugs to community pharmacies and the help of home health care providers limited therapeutic disruptions | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a France | |
650 | 4 | |a Outpatients | |
650 | 4 | |a Hospital pharmacy | |
650 | 4 | |a Medication adherence | |
650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
700 | 1 | |a Rofes, Guillaume Flandin |e verfasserin |4 aut | |
700 | 1 | |a Sorli, Sonia Caroline |e verfasserin |4 aut | |
700 | 1 | |a Cestac, Philippe |e verfasserin |4 aut | |
700 | 1 | |a Pages, Arnaud |e verfasserin |4 aut | |
700 | 1 | |a Eyvrard, Frédéric |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Sante publique (Vandoeuvre-les-Nancy, France) |d 1996 |g 35(2024), 6 vom: 23. Feb., Seite 39-51 |w (DE-627)NLM091707099 |x 0995-3914 |7 nnns |
773 | 1 | 8 | |g volume:35 |g year:2024 |g number:6 |g day:23 |g month:02 |g pages:39-51 |
856 | 4 | 0 | |u http://dx.doi.org/10.3917/spub.236.0039 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 35 |j 2024 |e 6 |b 23 |c 02 |h 39-51 |